메뉴 건너뛰기




Volumn 137, Issue 1, 2011, Pages 55-63

Circulating levels of angiogenic cytokines in advanced breast cancer patients with system chemotherapy and their potential value in monitoring disease course

Author keywords

Breast cancer; Chemotherapy; Endostatin; Survival; VEGF

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTOKINE; DOCETAXEL; ENDOSTATIN; EPIRUBICIN; NAVELBINE; PACLITAXEL; PIRARUBICIN; VASCULOTROPIN;

EID: 78751633481     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0859-y     Document Type: Article
Times cited : (8)

References (28)
  • 2
    • 0035985171 scopus 로고    scopus 로고
    • Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumours and poorer survival in non-small cell lung cancer patients
    • DOI 10.1016/S0169-5002(02)00027-2, PII S0169500202000272
    • D Brattström M Bergqvist P Hesselius A Larsson K Lamberg J Wernlund O Brodin G Wagenius 2002 Elevated preoperative serum levels of angiogenic cytokines correlate to larger primary tumors and poorer survival in non-small cell lung cancer patients Lung Cancer 37 57 63 10.1016/S0169-5002(02)00027-2 12057868 (Pubitemid 34621459)
    • (2002) Lung Cancer , vol.37 , Issue.1 , pp. 57-63
    • Brattstrom, D.1    Bergqvist, M.2    Hesselius, P.3    Larsson, A.4    Lamberg, K.5    Wernlund, J.6    Brodin, O.7    Wagenius, G.8
  • 3
    • 0034032882 scopus 로고    scopus 로고
    • Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer
    • 1:CAS:528:DC%2BD3cXisVynurk%3D 10766175
    • T Browder CE Butterfield BM Kraling B Shi B Marshall MS O'Reilly J Folkman 2000 Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer Cancer Res 60 1878 1886 1:CAS:528: DC%2BD3cXisVynurk%3D 10766175
    • (2000) Cancer Res , vol.60 , pp. 1878-1886
    • Browder, T.1    Butterfield, C.E.2    Kraling, B.M.3    Shi, B.4    Marshall, B.5    O'Reilly, M.S.6    Folkman, J.7
  • 4
    • 0035049240 scopus 로고    scopus 로고
    • Endogenous angiogenesis inhibitors and their therapeutic implications
    • DOI 10.1016/S1357-2725(01)00023-1, PII S1357272501000231
    • Y Cao 2001 Endogenous angiogenesis inhibitors and their therapeutic and their therapeutic implications Int J Biochem Cell Biol 33 357 369 1:CAS:528:DC%2BD3MXislGgtrg%3D 10.1016/S1357-2725(01)00023-1 11312106 (Pubitemid 32324004)
    • (2001) International Journal of Biochemistry and Cell Biology , vol.33 , Issue.4 , pp. 357-369
    • Cao, Y.1
  • 5
    • 0036225350 scopus 로고    scopus 로고
    • Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: Antitumor activity and correlation with vascular endothelial growth factor levels
    • 1:STN:280:DC%2BD387islyksw%3D%3D 10.1093/annonc/mdf013 11863115
    • M Colleoni A Rocca MT Sandri L Zorzino G Masci F Nole G Peruzzotti C Robertson L Orlando S Cinieri F de Braud G Viale A Goldhirsch 2002 Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels Ann Oncol 13 73 80 1:STN:280:DC%2BD387islyksw%3D%3D 10.1093/annonc/mdf013 11863115
    • (2002) Ann Oncol , vol.13 , pp. 73-80
    • Colleoni, M.1    Rocca, A.2    Sandri, M.T.3    Zorzino, L.4    Masci, G.5    Nole, F.6    Peruzzotti, G.7    Robertson, C.8    Orlando, L.9    Cinieri, S.10    De Braud, F.11    Viale, G.12    Goldhirsch, A.13
  • 6
    • 20044371835 scopus 로고    scopus 로고
    • Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: Correlation with treatment response and survival
    • DOI 10.1081/CNV-200055949
    • AZ Dudek H Mahaseth 2005 Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival Cancer Invest 23 193 200 1:CAS:528:DC%2BD2MXkslyhu7s%3D 10.1081/CNV-200055949 15945504 (Pubitemid 40770736)
    • (2005) Cancer Investigation , vol.23 , Issue.3 , pp. 193-200
    • Dudek, A.Z.1    Mahaseth, H.2
  • 7
    • 21344453004 scopus 로고    scopus 로고
    • Pharmacogenetics for individualized cancer chemotherapy
    • DOI 10.1016/j.pharmthera.2005.02.005, PII S0163725805000574
    • T Efferth M Volm 2005 Pharmacogenetics for individualized cancer chemotherapy Pharmacol Ther 107 155 176 1:CAS:528:DC%2BD2MXlvVWgtLs%3D 10.1016/j.pharmthera.2005.02.005 15890408 (Pubitemid 40910039)
    • (2005) Pharmacology and Therapeutics , vol.107 , Issue.2 , pp. 155-176
    • Efferth, T.1    Volm, M.2
  • 8
    • 0038779877 scopus 로고    scopus 로고
    • Circulating proangiogenic cytokines and angiogenesis inhibitor endostatin in untreated patients with chronic lymphocytic leukemia
    • DOI 10.1080/0962935031000134888
    • J Gora-Tybor JZ Bloski T Robak 2003 Circulating proangiogenic cytokines and angiogenesis inhibitor in untreatment patients with chronic lymphocytic leukemia Med Inflamm 12 167 171 1:CAS:528:DC%2BD3sXltlWnsb4%3D 10.1080/0962935031000134888 (Pubitemid 36871852)
    • (2003) Mediators of Inflammation , vol.12 , Issue.3 , pp. 167-171
    • Gora-Tybor, J.1    Blonski, J.Z.2    Robak, T.3
  • 9
    • 33750455512 scopus 로고    scopus 로고
    • Do serum angiogenic growth factors provide additional information to that of conventional markers in monitoring the course of metastatic breast cancer?
    • DOI 10.1159/000096072
    • AM Granato GL Frassineti N Giovannini M Ballardini O Nanni R Maltono D Amadori A Volpi 2006 Do serum angiogenic growth factors provide additional information to that of conventional markers in monitoring the course of metastatic breast cancer? Tumor Biol 27 302 308 1:CAS:528:DC%2BD28XhtFaks7rM 10.1159/000096072 (Pubitemid 44646224)
    • (2006) Tumor Biology , vol.27 , Issue.6 , pp. 302-308
    • Granato, A.M.1    Frassineti, G.L.2    Giovannini, N.3    Ballardini, M.4    Nanni, O.5    Maltoni, R.6    Amadori, D.7    Volpi, A.8
  • 10
    • 0030576517 scopus 로고    scopus 로고
    • Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
    • DOI 10.1016/S0092-8674(00)80108-7
    • D Hanahan J Folkman 1996 Patterns and emerging mechanism of the angiogenic switch during tumorigenesis Cell 86 353 364 1:CAS:528: DyaK28XltVSks7s%3D 10.1016/S0092-8674(00)80108-7 8756718 (Pubitemid 26272076)
    • (1996) Cell , vol.86 , Issue.3 , pp. 353-364
    • Hanahan, D.1    Folkman, J.2
  • 11
    • 34548542204 scopus 로고    scopus 로고
    • Does preoperative chemo-radiotherapy enhance the expression of vascular endothelial growth factor in patients with rectal cancer?
    • 1:CAS:528:DC%2BD2sXpsFGlt7c%3D 17611658
    • Y Inoue E Ojima J Watanabe Hiro Y Toiyama M Kobayashi C Miki M Kusunoki 2007 Does preoperative chemo-radiotherapy enhance the expression of vascular endothelial growth factor in patients with rectal cancer? Oncol Rep 18 369 375 1:CAS:528:DC%2BD2sXpsFGlt7c%3D 17611658
    • (2007) Oncol Rep , vol.18 , pp. 369-375
    • Inoue, Y.1    Ojima, E.2    Watanabe Hiro, J.3    Toiyama, Y.4    Kobayashi, M.5    Miki, C.6    Kusunoki, M.7
  • 12
    • 0037208589 scopus 로고    scopus 로고
    • Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer
    • 1:CAS:528:DC%2BD2cXpsVWru7Y%3D 10.1200/JCO.2003.10.066 12506171
    • F Kabbinavar HI Hurwitz L Fehrenbacher NJ Meropol WF Novotny G Lieberman S Griffing E Bergsland 2003 Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer J Clin Oncol 21 60 65 1:CAS:528: DC%2BD2cXpsVWru7Y%3D 10.1200/JCO.2003.10.066 12506171
    • (2003) J Clin Oncol , vol.21 , pp. 60-65
    • Kabbinavar, F.1    Hurwitz, H.I.2    Fehrenbacher, L.3    Meropol, N.J.4    Novotny, W.F.5    Lieberman, G.6    Griffing, S.7    Bergsland, E.8
  • 13
    • 0037426605 scopus 로고    scopus 로고
    • Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis
    • DOI 10.1016/S0304-3835(03)00047-8
    • AJ Karayiannakis H Bolanaki KN Syrigos B Asimakopoulos A Polychronidis S Anagnostoulis C Simopoulos 2003 Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis Cancer Lett 194 119 124 1:CAS:528:DC%2BD3sXjtFCjsLg%3D 10.1016/S0304-3835(03)00047-8 12706865 (Pubitemid 36428891)
    • (2003) Cancer Letters , vol.194 , Issue.1 , pp. 119-124
    • Karayiannakis, A.J.1    Bolanaki, H.2    Syrigos, K.N.3    Asimakopoulos, B.4    Polychronidis, A.5    Anagnostoulis, S.6    Simopoulos, C.7
  • 14
    • 0034989971 scopus 로고    scopus 로고
    • Vascular endothelial growth factor serum concentration changes during chemotherapy in patients with lung cancer
    • 1:CAS:528:DC%2BD3MXmtVOnu78%3D 11402619
    • Y Kido 2001 Vascular endothelial growth factor serum concentration changes during chemotherapy in patients with lung cancer Kurume Med J 48 43 47 1:CAS:528:DC%2BD3MXmtVOnu78%3D 11402619
    • (2001) Kurume Med J , vol.48 , pp. 43-47
    • Kido, Y.1
  • 15
    • 0034087691 scopus 로고    scopus 로고
    • Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
    • 1:CAS:528:DC%2BD3cXisFOlurc%3D 10.1172/JCI8829 10772661
    • G Klement S Baruchel J Rak S Man K Clark DJ Hicklin P Bohlen RS Kerbel 2000 Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity J Clin Investig 105 R15 R24 1:CAS:528:DC%2BD3cXisFOlurc%3D 10.1172/JCI8829 10772661
    • (2000) J Clin Investig , vol.105
    • Klement, G.1    Baruchel, S.2    Rak, J.3    Man, S.4    Clark, K.5    Hicklin, D.J.6    Bohlen, P.7    Kerbel, R.S.8
  • 16
    • 0034219424 scopus 로고    scopus 로고
    • Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: Which is the optimal specimen?
    • 1:CAS:528:DC%2BD3cXksV2qsr4%3D 10853032
    • JK Lee YJ Hong CJ Han DY Hwang SI Hong 2000 Clinical usefulness of serum and plasma vascular endothelial growth factor in cancer patients: which is the optimal specimen? Int J Oncol 17 149 152 1:CAS:528:DC%2BD3cXksV2qsr4%3D 10853032
    • (2000) Int J Oncol , vol.17 , pp. 149-152
    • Lee, J.K.1    Hong, Y.J.2    Han, C.J.3    Hwang, D.Y.4    Hong, S.I.5
  • 17
    • 0034521483 scopus 로고    scopus 로고
    • Chemotherapy and angiogenesis in advanced cancer: Vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancer
    • 1:CAS:528:DC%2BD3MXktVyktg%3D%3D
    • P Lissoni E Fugamalli A Ardizzoia S Secondino G Tancini GS Gardani 2000 Chemotherapy and angiogenesis in advanced cancer: vascular endothelial growth factor (VEGF) decline as predictor of disease control during taxol therapy in metastatic breast cancer Int J Biol Marker 15 308 311 1:CAS:528: DC%2BD3MXktVyktg%3D%3D
    • (2000) Int J Biol Marker , vol.15 , pp. 308-311
    • Lissoni, P.1    Fugamalli, E.2    Ardizzoia, A.3    Secondino, S.4    Tancini, G.5    Gardani, G.S.6
  • 18
    • 78751617744 scopus 로고    scopus 로고
    • Angiogenesis and vascular endothelial growth factor expression in invasive breast carcinomas after primary chemotherapy
    • FQ Meng L Li JM Zhang HY Wu JJ Nie 2001 Angiogenesis and vascular endothelial growth factor expression in invasive breast carcinomas after primary chemotherapy Chin Oncol 11 444 446
    • (2001) Chin Oncol , vol.11 , pp. 444-446
    • Meng, F.Q.1    Li, L.2    Zhang, J.M.3    Wu, H.Y.4    Nie, J.J.5
  • 20
    • 22244452376 scopus 로고    scopus 로고
    • VEGF-targeted therapy: Therapeutic potential and recent advances
    • DOI 10.1634/theoncologist.10-6-382
    • LS Rosen 2005 VEGF-targeted therapeutic potential and recent advances Oncologist 10 75 82 10.1634/theoncologist.10-6-382 (Pubitemid 40993566)
    • (2005) Oncologist , vol.10 , Issue.6 , pp. 382-391
    • Rosen, L.S.1
  • 21
    • 61449210829 scopus 로고    scopus 로고
    • Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast
    • 1:CAS:528:DC%2BD1MXitlWgtLc%3D 10.1007/s00432-008-0497-9 18936974
    • S Shivakumar BT Prabhakar K Jayashree MG Rajan BP Salimath 2009 Evaluation of serum vascular endothelial growth factor (VEGF) and microvessel density (MVD) as prognostic indicators in carcinoma breast J Cancer Res Clin Oncol 135 4 627 636 1:CAS:528:DC%2BD1MXitlWgtLc%3D 10.1007/s00432-008-0497-9 18936974
    • (2009) J Cancer Res Clin Oncol , vol.135 , Issue.4 , pp. 627-636
    • Shivakumar, S.1    Prabhakar, B.T.2    Jayashree, K.3    Rajan, M.G.4    Salimath, B.P.5
  • 22
    • 39749118576 scopus 로고    scopus 로고
    • Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancer
    • DOI 10.1007/s00280-007-0526-4
    • F Tas D Duranyildz HO Soydinc I Cicin M Selam K Uygun R Disci V Yasasever E Topuz 2008 Effect of maximum-tolerated doses and low-dose metronomic chemotherapy on serum vascular endothelial growth factor and thrombospondin-1 levels in patients with advanced nonsmall cell lung cancer Cancer Chemother Pharmacol 61 721 725 1:CAS:528:DC%2BD1cXitleru7w%3D 10.1007/s00280-007-0526-4 17554539 (Pubitemid 351302027)
    • (2008) Cancer Chemotherapy and Pharmacology , vol.61 , Issue.5 , pp. 721-725
    • Tas, F.1    Duranyildiz, D.2    Soydinc, H.O.3    Cicin, I.4    Selam, M.5    Uygun, K.6    Disci, R.7    Yasasever, V.8    Topuz, E.9
  • 23
    • 36849048282 scopus 로고    scopus 로고
    • Anti-vascular endothelial growth factor antibody bevacizumab in conjunction with chemotherapy in metastasising melanoma
    • DOI 10.1007/s00432-007-0251-8
    • P Terheyden MA Hofmann M Weininger FB Bröcker JC Becker 2007 Anti-vascular endothelial growth factor antibody bevacizumab in conjunction with chemotherapy in metastasising melanoma J Cancer Res Clin Oncol 133 11 897 901 1:CAS:528:DC%2BD2sXhtVWjsbvK 10.1007/s00432-007-0251-8 17583821 (Pubitemid 350218914)
    • (2007) Journal of Cancer Research and Clinical Oncology , vol.133 , Issue.11 , pp. 897-901
    • Terheyden, P.1    Hofmann, M.A.2    Weininger, M.3    Brocker, E.-B.4    Becker, J.C.5
  • 24
    • 0023719442 scopus 로고
    • Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer
    • 1:STN:280:DyaL1c3ltlaruw%3D%3D 3164256
    • C Tondini DF Hayes R Gelman IC Henderson DW Kufe 1988 Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer Cancer Res 48 4107 4112 1:STN:280:DyaL1c3ltlaruw%3D%3D 3164256
    • (1988) Cancer Res , vol.48 , pp. 4107-4112
    • Tondini, C.1    Hayes, D.F.2    Gelman, R.3    Henderson, I.C.4    Kufe, D.W.5
  • 25
    • 0033572338 scopus 로고    scopus 로고
    • The generation of endostatin is mediated by elastase
    • 1:CAS:528:DC%2BD3cXktFyisg%3D%3D 10626789
    • W Wen MA Moses D Wiederschain JL Arbiser J Folyman 1999 The generation of endostatin is mediated by elastase Cancer Res 59 6052 6056 1:CAS:528: DC%2BD3cXktFyisg%3D%3D 10626789
    • (1999) Cancer Res , vol.59 , pp. 6052-6056
    • Wen, W.1    Moses, M.A.2    Wiederschain, D.3    Arbiser, J.L.4    Folyman, J.5
  • 26
    • 4444286921 scopus 로고    scopus 로고
    • Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma
    • DOI 10.1093/annonc/mdh309
    • SS Yoon NH Segal AB Olshen MF Brennan S Singer 2004 Circulating angiogenic factor levels correlate with extent of disease and risk of recurrence in patients with soft tissue sarcoma Ann Oncol 15 1261 1266 1:STN:280:DC%2BD2cznt1Wltw%3D%3D 10.1093/annonc/mdh309 15277268 (Pubitemid 39199315)
    • (2004) Annals of Oncology , vol.15 , Issue.8 , pp. 1261-1266
    • Yoon, S.S.1    Segal, N.H.2    Olshen, A.B.3    Brennan, M.F.4    Singer, S.5
  • 27
    • 1642482608 scopus 로고    scopus 로고
    • Correlation between serum vascular endothelial growth factor and endostatin levels in patients with breast cancer
    • DOI 10.1016/j.canlet.2003.09.018
    • JH Zhao F Yan HX Ju JH Tang JW Qin XS Zhao 2004 Correlation between serum vascular endothelial growth factor and endostatin levels in patients with breast cancer Cancer Lett 204 87 95 1:CAS:528:DC%2BD2cXntV2jsg%3D%3D 10.1016/j.canlet.2003.09.018 14744538 (Pubitemid 38117197)
    • (2004) Cancer Letters , vol.204 , Issue.1 , pp. 87-95
    • Zhao, J.1    Yan, F.2    Ju, H.3    Tang, J.4    Qin, J.5
  • 28
    • 19544365867 scopus 로고    scopus 로고
    • The expression VEGF and Endostatin both in tissues and sera and the angiogenesis of breast cancer
    • 1:CAS:528:DC%2BD2MXhtFyjtLnK
    • JH Zhao JH Tang FQ Meng JW Qin XS Zhao 2005 The expression VEGF and Endostatin both in tissues and sera and the angiogenesis of breast cancer Chin J Clin Oncol 32 79 82 1:CAS:528:DC%2BD2MXhtFyjtLnK
    • (2005) Chin J Clin Oncol , vol.32 , pp. 79-82
    • Zhao, J.H.1    Tang, J.H.2    Meng, F.Q.3    Qin, J.W.4    Zhao, X.S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.